Improved Treatment Decisions Linked to Geriatric Consultations

Share this content:

the Cancer Therapy Advisor take:

Geriatric assessments provided aid in making treatment decisions for older patients with cancer, according to an article published online in the journal European Journal of Cancer Care.

In this study, the authors evaluated data on patients with cancer who were referred for geriatric consultation for clinical optimization or because of uncertainty regarding their optimal treatment strategy. The outcome of these geriatric evaluations, non-oncological interventions, and suggested treatment adaptations were also studied.

Participants included 72 patients who were referred for geriatric evaluation, over half of which were in a curative treatment setting.

Results showed the prevalence of geriatric syndromes was 93%. Almost half (49%) of patients had previously undiagnosed conditions identified and 56% of patients had non-oncological interventions initiated.

Patients discussed their priorities (53% of consultations), treatment expectations (50%), and advance care planning (14%).

Furthermore, 39% of patients were suggested to follow a more intensive optimal treatment, 42% were recommended a less intensive therapy, and 19% were recommended to solely follow supportive care.

FDA-approved immunotherapies are showing efficacy in different cancer types and combination therapie
Geriatric assessments provided aid in making treatment decisions for older patients with cancer.
Treatment decisions for elderly cancer patients can be challenging. A geriatric assessment may identify unknown medical conditions, give insight on patients' ability to tolerate treatment and guide treatment decisions. Our aim was to study the value of a geriatric consultation in oncological decision-making.
READ FULL ARTICLE From Wiley Online Library

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs